bioAffinity Technologies, Inc. - Common Stock (NQ: BIAF )
2.590
+0.150
(+6.15%)
Streaming Delayed Price
Updated: 3:39 PM EDT, Jul 12, 2024
Add to My Watchlist
Press Releases about bioAffinity Technologies, Inc. - Common Stock
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://mms.businesswire.com/media/20240709054084/en/797432/22/bioAfinity_logo.jpg)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://mms.businesswire.com/media/20240612944228/en/797432/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20240514817005/en/797432/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20240502141417/en/797432/22/bioAfinity_logo.jpg)
bioAffinity Technologies News Update
May 02, 2024
Via Business Wire
![](https://mms.businesswire.com/media/20240424118490/en/797432/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20240409551485/en/797432/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20240401275172/en/797432/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20240308198391/en/797432/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20240306247837/en/797432/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20240305481183/en/797432/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20240221772695/en/797416/22/bioAfinity_logo.jpg)
bioAffinity Technologies News Update
February 21, 2024
Via Business Wire
![](https://mms.businesswire.com/media/20240206573251/en/797432/22/bioAfinity_logo.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20240130175551/en/797416/22/bioAfinity_logo.jpg)
bioAffinity Technologies In The News
January 30, 2024
Via Business Wire
![](https://mms.businesswire.com/media/20240123142887/en/797432/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20240108702168/en/797416/22/bioAfinity_logo.jpg)
bioAffinity Technologies In the News
January 08, 2024
Via Business Wire
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://mms.businesswire.com/media/20231205195077/en/797416/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20231130362946/en/1956108/22/CyPathLung.jpg)
![](https://mms.businesswire.com/media/20231128477655/en/797432/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20231115775728/en/1945704/22/CyPathLung-Header-1x.jpg)
![](https://mms.businesswire.com/media/20231114135941/en/797416/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20231106271829/en/797416/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20231010755952/en/797432/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20230919752484/en/797416/22/bioAfinity_logo.jpg)
bioAffinity Technologies Acquires Laboratory Assets of Precision Pathology Services
September 19, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230907441683/en/797416/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20230814966396/en/797416/22/bioAfinity_logo.jpg)
![](https://mms.businesswire.com/media/20230712526323/en/797416/22/bioAfinity_logo.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.